ACXP Nilai Total Aset Perusahaan Acurx

The share price of Acurx Pharmaceuticals (ACXP) visualized below demonstrates total assets at 8.58, while the firm minimizes its own capacity by outsourcing production and testing to third-party contractors. Business dynamics remain independent of market fluctuations, as the development of agents against resistant bacteria is a global priority. Acurx Pharmaceuticals (ACXP) is currently focusing on its own proprietary developments, limiting its external activity to scientific collaboration with US clinics.

To assess the credit quality of Acurx Pharmaceuticals (ACXP), the analyst examines the total resource volume, reverse-calculated via ROA, to identify any hidden business degradation; meanwhile, the gross asset trend confirms the lightweight structure of the company, which utilizes outsourcing for production and testing to minimize capital expenditures, allowing the investor to interpret growth in this metric as an expansion of intellectual capital without the burden of heavy physical assets.